Protection from Flu Vaccination Reduced this Season

CDC's Morbidity and Mortality Weekly Report reported this season's vaccine offers reduced protection, which underscores the need for additional prevention and treatment efforts this season, including the use of influenza antiviral medications.

A CDC report shows that getting the flu vaccine this season reduced a person's risk of having to go to the doctor because of the flu by 23 percent among people of all ages. Overall estimates for each season have ranged from 10 percent to 60 percent effectiveness since the studies started in 2004-2005.

CDC's Morbidity and Mortality Weekly Report reported this season's vaccine offers reduced protection, which underscores the need for additional prevention and treatment efforts this season, including the use of influenza antiviral medications for treatment.

"Physicians should be aware that all hospitalized patients and all outpatients at high risk for serious complications should be treated as soon as possible with one of three available influenza antiviral medications if influenza is suspected, regardless of a patient's vaccination status and without waiting for confirmatory testing,” says Joe Bresee, branch chief in CDC's Influenza Division. "Health care providers should advise patients at high risk to call promptly if they get symptoms of influenza."

One factor that determines how well a flu vaccine works is the similarity between the flu viruses used in vaccine production and the flu viruses actually circulating. During seasons when vaccine viruses and circulating influenza viruses are well matched, VE between 50 and 60 percent has been observed. H3N2 viruses have been predominant so far this season, but about 70 percent of them have been different or have "drifted" from the H3N2 vaccine virus.

Product Showcase

  • Magid® Cool Powered by Mission®

    Magid® Cool Powered by Mission®

    Experience innovative cooling gear that cools instantly & lasts for hours with Magid® Cool Powered by Mission® from Magid®. This proprietary HydroActive™ fabric cools to 30 degrees below the average body temperature in under 60 seconds and stays cool for up to two hours. A new era of cooling gear includes towels, neck gaiters, head protection and clothing. Magid® is offering the first to market HydroActive™ flame retardant gaiter and towel for workers that require FR or ASTM F1506, NFPA 70E Compliance. Proprietary cooling technology is chemical-free, machine washable, reusable. 3

  • MSA ALTAIR io™ 4 Gas Detection Wearable

    MSA ALTAIR io™ 4 Gas Detection Wearable

    The MSA ALTAIR io™ 4 Gas Detection Wearable delivers real-time visibility to help drive safety and productivity across workers, worksites, and workflows. ALTAIR io 4 features: · Cutting-edge, CAT-M LTE cellular connectivity · Automatic integration with MSA Grid cloud-based software · Over-the-air (OTA) updates · Automatic bump test and calibration · MSA id digital device assignment · Rugged, durable design and industry-leading XCell® sensors The ALTAIR io 4 is part of the MSA Connected Work Platform. 3

  • Combustible Dust Testing & Process Consulting

    Combustible Dust Testing & Process Consulting

    Industrial Hygiene hazards should include potential combustibility hazards. Our labs provide testing for combustible dust, vapor and chemical reaction hazards. Fauske & Associates uses testing data to solve process safety issues and mitigate potential accidents in the chemical and nuclear industries. Custom solutions include site assessments, testing, engineering, consulting and training. 3

Featured